Aeterna Zentaris
AEZS
#10200
Rank
A$26.13 M
Marketcap
A$8.54
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$3.06. In 2022 the company made an earnings per share (EPS) of A-$6.98 a decrease over its 2021 EPS that were of A-$2.72.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.98157.14%
2021A-$2.72-41.48%
2020A-$4.64-64.46%
2019A-$13.06-240%
2018A$9.33-122.32%
2017A-$41.79-53.53%
2016A-$89.92-86.71%
2015A-$676.80-35.21%
2014A-$1,045-216.67%
2013A$895.44-123.3%
2012A-$3,843-40.8%
2011A-$6,492-6.45%
2010A-$6,940-27.91%
2009A-$9,626-61.61%
2008A-$25,07283.61%
2007A-$13,655-195.31%
2006A$14,327178.26%
2005A$5,149-330%
2004A-$2,239-80.05%
2003A-$11,22117.78%
2002A-$9,527515.93%
2001A-$1,547-68.6%
2000A-$4,927119.62%
1999A-$2,243-3.63%
1998A-$2,328

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
A-$0.54-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.98-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$4.43-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.53-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
A$7.30-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA